Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study

por Velhal, Gajanan D., Kamath, Yash V., Agrawal, Ansh S., Vora, Devanshi S., Dwivedi, Vaibhav R.
Publicado 2022